STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. VNRX
  4. [EFFECT] VolitionRX Limited SEC Filing

[EFFECT] VolitionRX Limited SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 14, 2025 5:00 P.M.
Form: S-3
CIK: 0000093314
Company Name: VOLITIONRX LTD
File Number: 333-288508

Source: View Original Filing on SEC EDGAR

Stock VNRX logo
Volitionrx

NYSE:VNRX

VNRX Rankings

#5681 Ranked by Market Cap
N/A Ranked by Dividends

VNRX Latest News

Dec 4, 2025
VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis
Nov 25, 2025
VolitionRx Limited Announces the First Sale of the Nu.Q® Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use
Nov 13, 2025
VolitionRx Limited Announces Third Quarter 2025 Financial Results and Business Update
Nov 10, 2025
VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update
Oct 17, 2025
Volition Donates Nu.Q® Vet Cancer Tests to HOPE Animal-Assisted Crisis Response Dogs

VNRX Latest SEC Filings

Nov 17, 2025
[Form 4] VOLITIONRX LTD Insider Trading Activity
Nov 14, 2025
[SCHEDULE 13G/A] VOLITIONRX LTD SEC Filing
Nov 13, 2025
[10-Q] VOLITIONRX LTD Quarterly Earnings Report
Nov 13, 2025
[8-K] VOLITIONRX LTD Reports Material Event
Nov 13, 2025
[8-K/A] VOLITIONRX LTD Amends Material Event Report

VNRX Stock Data

38.24M
101.74M
17.84%
22.29%
0.28%
Medical Devices
In Vitro & in Vivo Diagnostic Substances
Link
United States
HENDERSON